Copyright
©The Author(s) 2017.
World J Gastroenterol. Jul 28, 2017; 23(28): 5187-5195
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5187
Characteristics | P value |
Age (yr), mean ± SD (range) | 65 ± 10 (30-85) |
Gender | |
Male | 197 (58) |
Female | 145 (42) |
Length of follow-up (mo), median (IQR) | 11 (6-24) |
Venous thromboembolism | |
Pulmonary embolism | 9 (2.6) |
Deep venous thrombosis | 22 (6.4) |
Portal vein thrombosis | 2 (0.6) |
Port-a-Cath | 1 (0.3) |
Cumulative frequency | 34 (9.9) |
Khorana Class of risk | |
Low | 199 (58) |
Intermediate | 118 (35) |
High | 25 (7) |
Site of primary | |
Colon-rectum | 237 (69) |
Stomach | 38 (11) |
Pancreas | 36 (11) |
Biliary tract | 16 (5) |
Oesophagus | 15 (4) |
Stage of disease | |
Primary | 142 (42) |
Metastatic | 200 (58) |
Performance status (ECOG) | |
0 | 274 (80) |
1 | 60 (18) |
2 | 8 (2) |
Body mass index, mean ± SD (range) | 24.9 ± 4.0 (14.8-39.5) |
Normoweight | 200 (58) |
Overweight | 106 (31) |
Obese | 36 (11) |
Type 2 diabetes | 79 (23) |
Impaired glucose tolerance | 23 (7) |
- Citation: Guadagni F, Riondino S, Formica V, Del Monte G, Morelli AM, Lucchetti J, Spila A, D’Alessandro R, Della-Morte D, Ferroni P, Roselli M. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol 2017; 23(28): 5187-5195
- URL: https://www.wjgnet.com/1007-9327/full/v23/i28/5187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i28.5187